Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > °¨¿°Áúȯ > ¼¼°èÀÇ Ç×°¨¿°Á¦ ½ÃÀå(Ç×Áø±ÕÁ¦, Ç×»ýÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦)
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

¼¼°èÀÇ Ç×°¨¿°Á¦ ½ÃÀå(Ç×Áø±ÕÁ¦, Ç×»ýÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦)

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

¸®¼­Ä¡»ç Kalorama Information
¹ßÇàÀÏ 2009³â 10¿ù »óǰÄÚµå 101995
ÆäÀÌÁö Á¤º¸ 250 pages
°¡°Ý
US $ 3,500 £Ü 4,170,200 PDF by E-mail (Single User License)
US $ 3,900 £Ü 4,646,800 Hard Copy
US $ 4,200 £Ü 5,004,300 PDF by E-mail (Dept User License)
US $ 7,000 £Ü 8,340,500 PDF by E-mail (Global Site License)


Kalorama Information ¿¡¼­ 2009³â 10¿ù ¿¡ ¹ßÇàÇÑ ¡¸¼¼°èÀÇ Ç×°¨¿°Á¦ ½ÃÀå(Ç×Áø±ÕÁ¦, Ç×»ýÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦)¡¹ º¸°í¼­´Â 250 pages·Î ±¸¼ºµÇ¾î, US $3,500 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

Ç×Áø±ÕÁ¦, Ç×»ýÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦ °¢ ºÎ¹® ½ÃÀåÀÇ ÇöÀç »óȲ°ú ¿¹ÃøÀ» Á¤¸®Çϰí ÇöÀç Ãâ½ÃµÇ°í ÀÖ´Â Á¦Ç° ¹× Èı⠰³¹ß ´Ü°è¿¡ ÀÖ´Â Á¦Ç°ÀÇ °³¿ä, ¹Ì±¹, À¯·´À» Áß½ÉÀ¸·ÎÇÑ ¼¼°èÀÇ Ç×°¨¿°ÁõÁ¦ ½ÃÀåÀÇ Åë°è µ¥ÀÌÅ͸¦ ÀüÇØµå¸³´Ï´Ù.

    Á¦1Àå °³¿ä
    Á¦2Àå ¼­·Ð ¹× ¾÷°è µ¿Çâ
    • °³¿ä
    • º´¿ø±ÕÀÇ ¼­·Ð
    • ¼¼°èÀÇ Àα¸ Åë°è
    • Ç×°¨¿°Á¦ ³»¼º
    • HIV µ¿Çâ
    Á¦3Àå Ç×Áø±ÕÁ¦
    • °³¿ä
    • Áø±Õ °¨¿°ÀÇ Á¾·ù
    • Ç×Áø±ÕÁ¦ÀÇ °³¿ä
    • ½ÃÀå °³¿ä
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
    • Á¦Ç°º° ½ÃÀå
    • Áö¿ªº° ½ÃÀå
    • Ä¡·áº° ½ÃÀå ºÐ¼®
    • °æÇÕ ºÐ¼®
    Á¦4Àå Ç×»ýÁ¦
    • °³¿ä
    • Ç×±Õ »ý¹°ÀÇ ºÐ·ù
    • Ç×±ÕÀÇ ¹üÀ§
    • ¼¼±Õ ³»¼º
    • Ç×±Õ Ä¡·áÀÇ ¿ø¸®
    • º´¿ë ¿ä¹ý°ú ¿¹¹æ¾àÀÇ »ç¿ë
    • °¨¿° Åë°èÀÇ ¼¼±Õ
    • ¼¼±Õ °¨¿° ¼Õ½Ç
    • Ç×±Õ Á¦Ç° °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • Á¦Ç°º° ½ÃÀå
    • Áö¿ªº° ½ÃÀå
    • Ä¡·áº° ½ÃÀå ºÐ¼®
    • °æÇÕ ºÐ¼®
    • ÁÖ¿ä Á¦Ç°
    Á¦5Àå Ç× ¹ÙÀÌ·¯½ºÁ¦
    • °³¿ä : ¹ÙÀÌ·¯½ºÀÇ ¼­·Ð
    • º´¿ø±Õ¼º ¹ÙÀÌ·¯½ºÀÇ »ç·Ê
    • ¹ÙÀÌ·¯½ºÀÇ ±â´É°ú »ý¸íÀÇ ¿ª»ç
    • DNA ¹ÙÀÌ·¯½º º¹Á¦
    • RNA ¹ÙÀÌ·¯½º º¹Á¦
    • ·¹Æ®·Î ¹ÙÀÌ·¯½º º¹Á¦
    • ¹ÙÀÌ·¯½º ¹æ¾î
    • ¼÷ÁÖ ¼¼Æ÷·ÎÀÇ Ä§ÀÔ ¹× ¼÷ÁÖ ¹ÝÀÀ ȸÇǸ¦ À§ÇÑ ¹ÙÀÌ·¯½º °è·«
    • HIV¿Í AIDS
    • ¹ÙÀÌ·¯½º °¨¿° Åë°è
    • Ç× ¹ÙÀÌ·¯½º Á¦Ç°
    • ±âŸ Ç× ¹ÙÀÌ·¯½º Á¦Ç°
    • ½ÃÀå °³¿ä
    • ÃÑ ½ÃÀåÀÇ ±Ô¸ð ¹× ¿¹Ãø
    • ½ÃÀå ºÐ¼®
    • °æÇÕ ºÐ¼®
    • ÁÖ¿ä Á¦Ç°
    Á¦6Àå ½ÃÀå °³¿ä
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
    • ºÎ¹®º° ½ÃÀå
    Á¦7Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Introduction
    • Abbott Laboratories
    • AstraZeneca/MedImmune
    • Bayer Schering Pharma AG
    • Bristol-Myers Squibb
    • Daiichi Sankyo
    • Gilead Sciences
    • GlaxoSmithKline
    • Johnson & Johnson Group
    • Merck & Co.
    • Novartis
    • Pfizer
    • Roche
    • Schering-Plough Corporation
    • Wyeth
    ºÎ·Ï
    µµÇ¥
PMH
Back to Top